Obesity / body condition scoring

WSAVA guideline

Key findings

• One system clinic-wide; record the denominator; guidelines use the 9-point scale. Some extremely obese patients exceed 9/9 — no validated system beyond that point [GL2011 p.3].
• Ideal 4–5/9 "may appear 'too thin' to some pet owners so client education is important"; based on limited studies; risk in growing puppies may occur at low BCS (lab data) [GL2011 p.3].
• Palpation required for accuracy, especially medium–long coats; overweight animals show excess fat over the ribs or abdominal region yet muscle wasting remains palpable over bony prominences; per-score descriptors in Figs 2A/2B (image-only) [verify].
• Each BCS point ≈ 10–15% of body weight: NOT printed in any local extract [verify] — conventional Laflamme heuristic only, not WSAVA text.
• MCS complement: palpate temporal bones, scapulae, ribs, lumbar vertebrae (epaxial first), ilia; normal/mild/moderate/marked; early detection at "mild" valuable; muscle loss greater in disease ("stressed" vs simple starvation) [GL2011 pp.3–4].
• Obesity risks as printed: risk associations rise above 6/9 in adults; obesity-prone pets should NOT be free-fed; fast-growing large-breed puppies need portion control to BCS 4 of 9 to avoid joint/skeletal problems; canned food is more satiating to some cats — "may help treat and prevent obesity" [GL2011 p.6; FAQ 2018].
• Weight-loss plan as printed: comprehensive environment-modification plan (exercise, behaviour modification, and/or prescription weight control medication); confirm an 8-oz/237-ml measuring cup and measured amounts; meal vs free-choice individualized; adjust every 2 weeks initially to ideal BW/BCS [GL2011 p.8; FAQ 2018]. No target % BW loss/week or calorie-deficit % printed [verify].
• MER (NRC 2006): dog active 130 kcal × BWkg^0.75, inactive 95 kcal × BWkg^0.75; cat lean 100 kcal × BWkg^0.67 [exponent displaced in extract — verify], obese-prone 130 kcal × BWkg^0.4; needs vary ±50% 🐈 / ±30% 🐕 [Calorie sheets 2020; GL2011 p.7].
• kcal/day examples: dog 10 kg 470–590, 20 kg 790–993, 40 kg 1340–1670; cat 4 kg 225–250, 7 kg 280–370 [Calorie sheets].

Drugs named in WSAVA’s own guideline text

As printed in WSAVA’s document, not this app’s own extracted data — see “Related drugs in this reference” below for that.

• Prescription weight-control medication — [dose not printed in source]

  Obesity plan adjunct — "exercise, behavior modification, and/or prescription weight control medication"; no agent named [GL2011 p.8]

• Diuretics (class example) — [dose not printed in source]

  Extended evaluation: "medications (e.g., diuretics)… can cause a loss or malabsorption of essential nutrients" [GL2011 p.5]

• Essential fatty acid supplement — [dose not printed in source]

  Only add-on supplement FAQ endorses: long-coated breeds "may require slightly higher essential fatty acid intakes" [FAQ 2018]

Recommendations

• Use the 9-point BCS consistently, record denominator; ideal 4–5/9

  Guideline ("panel recommends"); limited studies acknowledged

• Score MCS at every visit — overweight pets can have marked muscle loss

  Guideline + GNC MCS chart (expert consensus)

• BCS <4 or >5 = Table 1 screening risk factor → consider extended evaluation

  Guideline (Table 1)

• If obese: comprehensive environment plan (exercise, behaviour modification ± weight-control medication)

  Guideline (Action section)

• Confirm 8-oz/237-ml measuring cup; measured amounts; individualize meal vs free choice

  Guideline

• No free-feeding obesity-prone pets; portion-control large-breed puppies to BCS 4/9

  Expert consensus (GNC FAQ)

• Start from MER formula/label; expect ±50% 🐈 / ±30% 🐕 variation; adjust every 2 weeks

  GNC Calorie sheets + FAQ ("guidance only… individuals")

• Weight-loss rate targets/drug doses absent — seek other sources [verify]

  Gap flag

Related drugs in this reference (0)

No indication text currently matches this condition by name. Try a broader condition or search the drug reference directly. Absence of a match does not establish that treatment is unavailable.